Results 81 to 90 of about 100,846 (313)

CORRECTION: The capacity of imaging sonar for quantifying the abundance, species richness, and size of reef fish assemblages

open access: hybrid, 2023
ECP Sibley   +5 more
openalex   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Changes in the ichthyofauna of an artificial reef in the southeastern Mediterranean in one decade

open access: yesScientia Marina, 2000
Species composition and numbers of bony fish were studied in a small artificial reef complex off the northern Mediterranean coast of Israel. On this site visual censuses of fish carried out by SCUBA divers once a month over a twelve month period in 1985 ...
E. Spanier
doaj   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Effects of the hydrological regime on the ichthyofauna of riverine environments of the Upper Paraná River floodplain

open access: yesBrazilian Journal of Biology
In this work, spatial and temporal variations in the diversity (species richness and Simpson's Diversity Index) and abundance (indexed by the capture per unit effort - CPUE; total and for reproductive groups) of fish from three rivers (Baía, Ivinheima ...
R. Fernandes   +6 more
doaj   +1 more source

Practice of assessing the resources of fish in Peter the Great Bay by data of Danish seine catches

open access: yesИзвестия ТИНРО, 2018
Marine biological resources are usually assessed by trawl surveys; methods of these surveys are well-developed. However, number of fish populations is too high to be completely assessed by scientific surveys, so the data of commercial fishery have to be ...
L. N. Kim, D. V. Izmyatinsky
doaj   +1 more source

How do changes in flow magnitude due to hydropower operations affect fish abundance and biomass in temperate regions? A systematic review. [PDF]

open access: yesEnviron Evid, 2022
Harper M   +10 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy